ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,540Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 345

$666K Total Retail Price of All Prescriptions

Rank: 8 out of 345

686 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 12,433 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
LISINOPRIL 1,008 797 1 1
FUROSEMIDE 763 588 2 6
METOPROLOL TARTRATE 748 569 3 4
SIMVASTATIN 729 618 4 7
AMLODIPINE BESYLATE 653 505 5 5
METOPROLOL SUCCINATE 575 452 6 3
WARFARIN SODIUM 568 488 7 8
CARVEDILOL 515 341 8 2
PRAVASTATIN SODIUM 481 386 9 14
LEVOTHYROXINE SODIUM 348 307 10 27
CLOPIDOGREL 329 226 11 11
LOSARTAN POTASSIUM 317 254 12 12
OMEPRAZOLE 306 259 13 26
ATENOLOL 299 254 14 13
HYDROCHLOROTHIAZIDE 299 253 14 17
ISOSORBIDE MONONITRATE ER 285 233 16 10
XARELTO 266 253 10 17 70
ATORVASTATIN CALCIUM 261 205 18 9
CRESTOR 238 160 19 15
ZOLPIDEM TARTRATE 230 207 20 56
PLAVIX 195 140 21 16
NITROSTAT 189 132 22 24
POTASSIUM CHLORIDE 183 174 23 23
DIGOXIN 179 144 24 18
PRADAXA 146 134 25 20
LOSARTAN-HYDROCHLOROTHIAZIDE 143 97 26 35
NEXIUM 135 114 27 55
TRAMADOL HCL 107 90 28 60
TAMSULOSIN HCL 94 88 29 72
HYDRALAZINE HCL 92 73 30 34
GLIMEPIRIDE 92 72 30 64
KLOR-CON M20 91 49 32 30
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 72 33 42
METFORMIN HCL 90 59 33 38
CLONIDINE HCL 90 60 33 40
DIOVAN 89 65 36 25
DILTIAZEM 24HR ER 87 86 37 29
FAMOTIDINE 87 86 37 86
TORSEMIDE 82 79 39 69
AMOXICILLIN 79 46 40 81
RAMIPRIL 79 64 40 31
ALLOPURINOL 78 60 42 59
SERTRALINE HCL 76 43 43 75
RANITIDINE HCL 76 44 43 49
CITALOPRAM HBR 74 67 45 95
FENOFIBRATE 74 45 45 47
ENALAPRIL MALEATE 72 41 47 32
SPIRONOLACTONE 72 66 47 19
LANSOPRAZOLE 71 46 49 111
DIOVAN HCT 71 51 49 51
BYSTOLIC 69 64 51 22
NAMENDA 68 60 52 144
DILTIAZEM 24HR CD 63 63 53 36
EFFIENT 63 44 53 58
ISOSORBIDE DINITRATE 63 63 53 57
AZITHROMYCIN 62 45 56 83
JANUVIA 62 41 56 97
BENAZEPRIL HCL 62 62 56 62
VITAMIN D2 54 31 59 162
PROAIR HFA 54 51 59 94
DONEPEZIL HCL 50 49 61 118
MECLIZINE HCL 50 42 61 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 17, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.